Benitec Biopharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	188.79	97.74	50.87	2.48	4.06	19.77
Cash & Short-Term Investments	188.79	97.74	50.87	2.48	4.06	19.77
Cash Growth	141.16%	92.16%	1953.53%	-39.02%	-79.45%	101.68%
Accounts Receivable	0.13	-	-	0.06	0	0.03
Other Receivables	-	0.03	0.23	-	-	-
Receivables	0.13	0.03	0.23	0.06	0	0.03
Prepaid Expenses	0.56	0.63	0.52	1.18	0.74	0.8
Restricted Cash	0.11	0.11	0.06	0.01	0.01	0.02
Total Current Assets	189.6	98.52	51.67	3.73	4.82	20.61
Property, Plant & Equipment	1.02	0.99	0.45	0.61	0.99	0.58
Other Long-Term Assets	0.07	0.08	0.09	0.12	0.16	0.19
Total Assets	190.68	99.59	52.21	4.46	5.97	21.38
Accounts Payable	1.02	0.2	1.35	1.14	0.42	0.27
Accrued Expenses	0.62	0.52	0.65	0.74	0.7	0.49
Current Portion of Leases	0.47	0.35	0.28	0.28	0.25	0.21
Other Current Liabilities	0.7	0.72	2.64	1.82	1.16	0.39
Total Current Liabilities	2.8	1.8	4.92	3.98	2.53	1.37
Long-Term Leases	0.52	0.5	-	0.28	0.56	-
Pension & Post-Retirement Benefits	-	-	0.04	-	-	-
Total Liabilities	3.32	2.3	4.96	4.26	3.09	1.37
Common Stock	0	0	0	-	-	0
Additional Paid-In Capital	437.22	326.31	238.4	168.92	152.45	151.58
Retained Earnings	-248.98	-228.18	-190.26	-167.89	-148.33	-130.12
Comprehensive Income & Other	-0.88	-0.84	-0.89	-0.83	-1.25	-1.46
Shareholders' Equity	187.36	97.3	47.25	0.2	2.88	20.01
Total Liabilities & Equity	190.68	99.59	52.21	4.46	5.97	21.38
Total Debt	0.99	0.85	0.28	0.56	0.81	0.21
Net Cash (Debt)	187.8	96.9	50.58	1.92	3.25	19.56
Net Cash Growth	140.32%	91.56%	2537.23%	-41.00%	-83.38%	108.11%
Net Cash Per Share	4.49	2.68	2.75	1.38	6.76	77.40
Filing Date Shares Outstanding	34.35	26.25	10.56	2.55	0.48	0.48
Total Common Shares Outstanding	34.25	26.25	10.09	1.65	0.48	0.48
Working Capital	186.79	96.72	46.75	-0.25	2.29	19.24
Book Value Per Share	5.47	3.71	4.68	0.12	6.00	41.63
Tangible Book Value	187.36	97.3	47.25	0.2	2.88	20.01
Tangible Book Value Per Share	5.47	3.71	4.68	0.12	6.00	41.63
Machinery	1.58	1.57	1.55	1.38	1.37	1.36
Leasehold Improvements	0.02	0.02	0.02	0.02	0.02	0.02

Updated Feb 12, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q